ATEZOLIZUMAB
atezolizumab 1.875 g/15 mL injection, 15 mL vial
ATEZOLIZUMAB (14289C)
14289C
Manner of administration:Injection
Restriction 18257
Indication: Extensive-stage small cell lung cancer
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 3 | DPMQ: $6,747.37 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tecentriq SC | |||||